Intra-Cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. TSLA

Go back to Intra-Cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Misses Q2 EPS by 5c

August 10, 2020 7:33 AM EDT

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q2 EPS of ($0.96), $0.05 worse than the analyst estimate of ($0.91). Revenue for the quarter came in at $1.91 million versus the consensus estimate of $3.03 million.

We have completed our first full quarter of commercial activities, adapting to the unprecedented... More